Inactive Instrument
InterCure Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
INCR
IL0011063760
Healthcare Facilities & Services
| Market Cap | 194M 597M 171M 162M 147M 276M 18.64B 279M 1.95B 750M 9.52B 729M 714M 30.63B | P/E 2024 |
-4.01x | P/E 2025 | -4.87x |
|---|---|---|---|---|---|
| Enterprise Value | 331M 1.02B 292M 276M 250M 469M 31.72B 474M 3.31B 1.28B 16.2B 1.24B 1.21B 52.13B | EV / Sales 2024 |
1.69x | EV / Sales 2025 | 1.16x |
| Free-Float |
60.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 2019-12-23 | |
Amos Cohen
DFI | Director of Finance/CFO | 47 | 2020-02-29 |
Itai Kabiljo
LAW | General Counsel | - | 2022-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 2015-09-02 | |
David Salton
BRD | Director/Board Member | 66 | 2014-12-13 |
| Chairman | 55 | 2025-02-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -0.51% | - | - | 63.2M | |
| -1.27% | +4.03% | -6.91% | +288.71% | 379M | |
| -1.96% | -4.46% | -45.26% | -16.67% | 149M | |
| +1.85% | +3.77% | +21.55% | +129.17% | 153M | |
| 0.00% | +6.78% | -13.70% | -33.68% | 128M | |
| +1.93% | -0.06% | -37.73% | -45.71% | 63.2M | |
| Average | +0.13% | +2.01% | -16.41% | +64.36% | 174.48M | |
| Weighted average by Cap. | -0.38% | +2.64% | -11.69% | +137.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 239M 734M 211M 199M 181M 339M 22.92B 342M 2.39B 922M 11.7B 897M 877M 37.66B | 270M 831M 238M 226M 205M 384M 25.93B 387M 2.71B 1.04B 13.24B 1.01B 993M 42.61B |
| Net income | -67.8M -208M -59.83M -56.61M -51.34M -96.25M -6.51B -97.2M -679M -262M -3.32B -255M -249M -10.69B | -35.71M -110M -31.51M -29.82M -27.04M -50.7M -3.43B -51.2M -358M -138M -1.75B -134M -131M -5.63B |
| Net Debt | 133M 408M 117M 111M 101M 188M 12.74B 190M 1.33B 512M 6.5B 498M 488M 20.93B | 136M 419M 120M 114M 103M 194M 13.08B 195M 1.37B 526M 6.68B 512M 501M 21.5B |
Employees
-
